James Dennewill
Fortune : 3 M $ au 31/08/2026
Fortune : 3 M $ au 31/08/2026
James Dennewill is the Chief Operating Officer at SpyGlass Pharma, Inc. since 2021, with employment at the company starting in 2019.
Formerly, Mr. Dennewill was the Chief Operating Officer at Cianna Medical, Inc. Education includes an undergraduate degree from The California State University and an MBA from Yale School of Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPYGLASS PHARMA, INC. 0,29 % | 05/02/2026 | 96 022 ( 0,29 % ) | 3 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SPYGLASS PHARMA, INC. | Directeur des opérations | 01/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Directeur des opérations | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
The California State University
The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Health Technology |
Yale School of Management
Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpyGlass Pharma Inc
SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national